NFE2L2 and cancer: The anti-cancer activity of α-Tocopheryl succinate may be due to its ability in inhibiting oxidative phosphorylation at the level of mitochondrial complexes I and II, enhancing ROS generation which, in turn, activate the expression of NRF2-dependent antioxidant genes [99,100].